Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS)
CNY 8.87
(2.31%)
CNY 8.87
(2.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -166.22 Million | -92.55 Million | -12.37 Million | 56.16 Million | 56.19 Million | -33.49 Million |
| Net Income | -76.06 Million | -124.2 Million | -29.98 Million | 39.77 Million | 33.64 Million | 8.61 Million |
| Depreciation & Amortization | 45.1 Million | 37.85 Million | 30.21 Million | 21.63 Million | 21.63 Million | 19.95 Million |
| Deferred income taxes | -16.01 Million | -18.53 Million | -12.28 Million | 119.74 Thousand | 2.82 Million | -1.07 Million |
| Stock-based compensation | 9.62 Million | 11.49 Million | - | - | - | - |
| Change in working capital | -160.17 Million | -40.94 Million | -13.77 Million | -6.47 Million | -14.06 Million | -69.78 Million |
| Other non-cash items | 24.91 Million | 41.77 Million | 1.17 Million | 1.24 Million | 14.97 Million | 7.7 Million |
| Investing Cash Flow | 73.44 Million | -405.72 Million | 230.52 Million | -574.44 Million | -37 Million | -82.49 Million |
| Investments in PPE | -71.2 Million | -140.29 Million | -94.78 Million | -42.42 Million | -33.49 Million | -89.5 Million |
| Acquisitions | 1.32 Million | 683.11 Thousand | 10 Thousand | 400.00 | - | 150.4 Thousand |
| Investment purchases | -970 Million | -87.75 Million | -60.87 Million | -1.03 Billion | -4.03 Million | - |
| Sales/Maturities of investments | 8.32 Million | 8.64 Million | 14.17 Million | 2.98 Million | - | 1.41 Million |
| Other Investing Activities | 1.1 Billion | -186.99 Million | 371.99 Million | 503 Million | 527.19 Thousand | 5.59 Million |
| Financing Cash Flow | 190.78 Million | 196.03 Million | -22.92 Million | 626.7 Million | 23.44 Million | 37.8 Million |
| Debt repayment | -195 Million | -205 Million | -2.76 Million | -191.99 Million | -101 Million | -60 Million |
| Dividends payments | -11.65 Million | -3.46 Million | -20.16 Million | -3.12 Million | -5.6 Million | -3.19 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.14 Million | 404.49 Million | -0.29 | 821.82 Million | 130.04 Million | 100.99 Million |
| Accounts receivables | -82.92 Million | -66.65 Million | 31.34 Million | 34.06 Million | -20.86 Million | -100.48 Million |
| Accounts payables | -8.84 Million | 118.86 Million | 3.86 Million | -17.3 Million | 3.59 Million | 31.89 Million |
| Inventory | -52.39 Million | -74.61 Million | -36.69 Million | -23.36 Million | 388.62 Thousand | -114.1 Thousand |
| Other working capital | -16.01 Million | -18.53 Million | -12.28 Million | 119.74 Thousand | 2.82 Million | -69.66 Million |
| Cash at beginning of period | 123.8 Million | 425.57 Million | 230.49 Million | 122.22 Million | 79.64 Million | 158.21 Million |
| Cash at end of period | 221.8 Million | 123.8 Million | 425.57 Million | 230.49 Million | 122.22 Million | 79.64 Million |
| Capital Expenditure | -71.2 Million | -140.29 Million | -94.78 Million | -42.42 Million | -33.49 Million | -89.5 Million |
| Effect of forex changes on cash | 1433.42 | 467.67 Thousand | -150.99 Thousand | -156.12 Thousand | -51.54 Thousand | -369.89 Thousand |
| Net cash flow / Change in cash | 97.99 Million | -301.77 Million | 195.08 Million | 108.26 Million | 42.58 Million | -78.56 Million |
| Free Cash Flow | -237.42 Million | -232.85 Million | -107.15 Million | 13.73 Million | 22.69 Million | -123 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.5 Million | -31.82 Million | -13.6 Million | -43.61 Million | -76.06 Million | -22.85 Million |
| Depreciation & Amortization | - | 12.66 Million | 12.66 Million | 12.16 Million | 45.1 Million | -22.18 Million |
| Deferred income taxes | - | - | - | 128.49 Million | -16.01 Million | -114.5 Million |
| Stock-based compensation | - | 3.75 Million | - | 9.62 Million | 9.62 Million | -5.87 Million |
| Change in working capital | - | -40.06 Million | - | -138.11 Million | -160.17 Million | 140.51 Million |
| Other non-cash items | 93.79 Million | 37.92 Million | -55.17 Million | 103.36 Million | 24.91 Million | 34.41 Million |
| Investing Cash Flow | -18.29 Million | 21.86 Million | 44.48 Million | -52.71 Million | 73.44 Million | 219.3 Thousand |
| Investments in PPE | -15.16 Million | -7.47 Million | -25.52 Million | -18.48 Million | -71.2 Million | -6.8 Million |
| Acquisitions | 1789.92 | - | - | -73.26 Thousand | 1.32 Million | 1.27 Million |
| Investment purchases | 370.65 Million | -370.65 Million | - | -970 Million | -970 Million | 505 Million |
| Sales/Maturities of investments | - | 1.47 Million | 1.54 Million | 627.73 Thousand | 8.32 Million | 2.05 Million |
| Other Investing Activities | -373.78 Million | 399.98 Million | 70 Million | 935.21 Million | 1.1 Billion | -501.29 Million |
| Financing Cash Flow | 73.82 Million | -54.5 Million | 35.85 Million | 5.25 Million | 190.78 Million | 31.34 Million |
| Debt repayment | -78.56 Million | -50.05 Million | -40 Million | -86 Million | -195 Million | -9 Million |
| Dividends payments | - | -3.69 Million | -3.6 Million | -3.73 Million | -11.65 Million | -3.29 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.73 Million | -4.45 Million | -4.14 Million | -907.77 Thousand | 2.14 Million | 43.63 Million |
| Accounts receivables | - | -11.9 Million | - | -82.92 Million | -82.92 Million | 117.12 Million |
| Accounts payables | - | - | - | - | -8.84 Million | 5.66 Million |
| Inventory | - | -31.9 Million | - | -52.39 Million | -52.39 Million | 23.38 Million |
| Other working capital | - | 3.75 Million | - | -2.79 Million | -16.01 Million | -5.66 Million |
| Cash at beginning of period | 216.58 Million | 256.84 Million | 225.35 Million | 325.76 Million | 123.8 Million | 284.69 Million |
| Cash at end of period | 337.14 Million | 216.58 Million | 256.84 Million | 221.8 Million | 221.8 Million | 325.76 Million |
| Capital Expenditure | -15.16 Million | -7.47 Million | -25.52 Million | -18.48 Million | -71.2 Million | -6.8 Million |
| Effect of forex changes on cash | - | 23.45 Thousand | 9368.29 | 80.28 Thousand | 1433.42 | 2206.04 |
| Net cash flow / Change in cash | 120.56 Million | -40.26 Million | 31.48 Million | -103.95 Million | 97.99 Million | 41.06 Million |
| Free Cash Flow | 63.12 Million | -14.03 Million | -94.3 Million | -75.06 Million | -237.42 Million | 2.69 Million |
CONART
GAU
SU
SGY
TROY
002347